SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-06-063846
Filing Date
2006-09-28
Accepted
2006-09-28 17:24:34
Documents
8
Period of Report
2006-11-02
Effectiveness Date
2006-09-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT a06-20221_1def14a.htm DEF 14A 674528
2 GRAPHIC g202211dci001.gif GRAPHIC 3105
3 GRAPHIC g202211dci002.gif GRAPHIC 1742
4 GRAPHIC g202211dsi001.gif GRAPHIC 24739
5 GRAPHIC g202211dsi002.gif GRAPHIC 2967
6 GRAPHIC g202211dai001.gif GRAPHIC 3105
7 GRAPHIC g202211dai002.gif GRAPHIC 1742
8 GRAPHIC g202211dei001.gif GRAPHIC 3105
  Complete submission text file 0001104659-06-063846.txt   732784
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-16633 | Film No.: 061114867
SIC: 8071 Services-Medical Laboratories